
Positive topline results in trial for patients with early breast cancer
Patients with early breast cancer (EBC) could benefit from a targeted treatment that can block or interfere with cancer cell growth.
Patients with early breast cancer (EBC) could benefit from a targeted treatment that can block or interfere with cancer cell growth.